Analysts think NUVB stock price could increase by 112%
Sep 13, 2025, 11:25 AM
19.49%
What does NUVB do
Nuvation Bio, based in San Francisco, develops novel oncology therapies and has 159 employees. Its clinical portfolio includes candidates like taletrectinib and safusidenib, targeting specific cancer mutations.
8 analysts think NUVB stock price will increase by 111.82%. The current median analyst target is $6.63 compared to a current stock price of $3.13. The lowest analysts target is $6.06 and the highest analyst target is $10.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.